Boston biotech recruits Sanofi’s US cancer research chief; Syndax in-licenses Allergan portfolio
→Boston-based Silicon Therapeutics has recruited Sanofi’s US cancer R&D chief Christopher Winter to come over and run the R&D side of the business. Silicon …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.